Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Transposon Mutagenesis of Probiotic Lactobacillus casei Identifies asnH, an Asparagine Synthetase Gene Involved in Its Immune-Activating Capacity

  • Masahiro Ito,

    Affiliation Department of Microbiology, School of Pharmacy, Kitasato University, Minato-ku, Tokyo, Japan

    ⨯
  • Yun-Gi Kim,

    Affiliation Department of Microbiology, School of Pharmacy, Kitasato University, Minato-ku, Tokyo, Japan

    ⨯
  • Hirokazu Tsuji,

    Affiliation Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan

    ⨯
  • Takuya Takahashi,

    Affiliation Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan

    ⨯
  • Mayumi Kiwaki,

    Affiliation Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan

    ⨯
  • Koji Nomoto,

    Affiliation Yakult Central Institute for Microbiological Research, Kunitachi, Tokyo, Japan

    ⨯
  • Hirofumi Danbara,

    Affiliation Department of Microbiology, School of Pharmacy, Kitasato University, Minato-ku, Tokyo, Japan

    ⨯
  • Nobuhiko Okada

    okadan@pharm.kitasato-u.ac.jp

    Affiliation Department of Microbiology, School of Pharmacy, Kitasato University, Minato-ku, Tokyo, Japan

    ⨯

Abstract

Lactobacillus casei ATCC 27139 enhances host innate immunity, and the J1 phage-resistant mutants of this strain lose the activity. A transposon insertion mutant library of L. casei ATCC 27139 was constructed, and nine J1 phage-resistant mutants out of them were obtained. Cloning and sequencing analyses identified three independent genes that were disrupted by insertion of the transposon element: asnH, encoding asparagine synthetase, and dnaJ and dnaK, encoding the molecular chaperones DnaJ and DnaK, respectively. Using an in vivo mouse model of Listeria infection, only asnH mutant showed deficiency in their ability to enhance host innate immunity, and complementation of the mutation by introduction of the wild-type asnH in the mutant strain recovered the immuno-augmenting activity. AsnH protein exhibited asparagine synthetase activity when the lysozyme-treated cell wall extracts of L. casei ATCC 27139 was added as substrate. The asnH mutants lost the thick and rigid peptidoglycan features that are characteristic to the wild-type cells, indicating that AsnH of L. casei is involved in peptidoglycan biosynthesis. These results indicate that asnH is required for the construction of the peptidoglycan composition involved in the immune-activating capacity of L. casei ATCC 27139.

Citation: Ito M, Kim Y-G, Tsuji H, Takahashi T, Kiwaki M, Nomoto K, et al. (2014) Transposon Mutagenesis of Probiotic Lactobacillus casei Identifies asnH, an Asparagine Synthetase Gene Involved in Its Immune-Activating Capacity. PLoS ONE 9(1): e83876. https://doi.org/10.1371/journal.pone.0083876

Editor: Valerie de Crécy-Lagard, University of Florida, United States of America

Received: August 20, 2013; Accepted: November 8, 2013; Published: January 8, 2014

Copyright: © 2014 Ito et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This study was supported in part by a Grant-in-Aid for Young Scientists B (23790485 to MI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. This work was also funded in part by a Kitasato University Research Grant for Young Researchers (2012 to MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: Hirokazu Tsuji, Takuya Takahashi, Mayumi Kiwaki, and Koji Nomoto are employees of Yakult Central Institute for Microbiological Research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Introduction

Probiotics are defined as live microorganisms which, when administered in sufficient amounts, confer health benefits in the host in addition to their nutritional effects [1]. Among the various health-promoting functions of the probiotics, much attention has been paid to their immune regulatory activity, since they are often used both in clinical applications and as foods that function to maintain the immunologic homeostasis of the host [1], [2].

Lactobacilli are the normal commensals in the human intestines, and certain Lactobacillus strains are regarded as probiotic bacteria. L. casei strain Shirota has been widely studied for its probiotic effects including immunomodulating activity. It enhances NK cell activity by dairy intake [3], [4] and prevents and reduces the risk of recurrence of bladder cancer by oral administration in human [5], [6]. In addition, this strain also enhances anti-infectious activity against Listeria monocytogenes [7], [8] and Pseudomonas aeruginosa [9] and inhibits the growth of transplantable allogeneic and syngeneic mouse tumors in several experimental animal models [10]–[14]. However, the detailed molecular mechanisms involved in these processes have not been understood.

L. casei ATCC 27139, the parental strain of Shirota [15], has been consistently shown to exhibit anti-infectious activity against L. monocytogenes and anti-tumor activity against MethA fibrosarcoma in mice associated with the marked increases in the cytokine levels such as TNF-α, IL-12, IL-18, and IFN-γ [16]. Although L. casei ATCC 27139 is susceptible to J1 phage, which shows a remarkably high specificity to certain strains of L. casei/L. paracasei [17], J1 phage-resistant mutants of this strain have been reported to be deficient in the immune-activating capacity [16], suggesting that the bacterial components associated with J1 phage sensitivity may be related to the activity. Despite the probable relationship between the J1 phage sensitivity and the immune-activating capacity of this strain, the genetic determinants responsible for J1 phage resistance have not been identified because of the technical limitation of the introduction of mutagenesis using chemical mutagen.

Recently, we developed a random mutagenesis system using a Tn5-based EZ::TN transposome for the probiotic L. casei ATCC 27139 [18]. Using this system, we constructed a Tn5 insertion library of nearly 10,000 transposon insertion mutants of L. casei ATCC 27139 that represents the first genome-wide random mutagenesis approach for lactobacilli [18]. Analysis of the transposon insertion mutants by Southern hybridization and sequencing of transposon insertion sites confirmed non-biased transposon insertion events [18]. Using a part of the Tn5 insertion library, we have identified the genes responsible for amino acid auxotrophy, glycine or alanine biosynthesis, respectively, which further allowed the validation of the usefulness of this library [18].

In this study, we describe the identification of the gene required both for the J1 phage sensitivity and the immune-activating capacity of L. casei ATCC 27139 using a Tn5 insertion library. In addition, correlation between probiotic function of L. casei ATCC 27139 and cell wall structure was studied.

Materials and Methods

Bacterial strains, phage, and growth conditions

L. casei ATCC 27139 was used as the wild-type strain. Lactobacilli were cultured in ILS medium [18]. The virulent L. monocytogenes strain EGD, was grown in brain heart infusion medium (Becton Dickinson and Co., Franklin Lakes, NJ) prior to infecting the mice. Escherichia coli JM109 was used as the host organism for molecular cloning and expression of recombinant proteins. E. coli strains were cultured in Luria–Bertani (LB) medium.

A random transposon mutant library was generated using an Tn5 transposon insertion as described previously [18]. A total of nearly 10,000 mutants were arrayed in a 96-well plate and stored at −80°C in 40% glycerol.

J1 phage was obtained from the American Type Culture Collection (ATCC 27139-B1). After many rounds of phage multiplication in L. casei ATCC 27139, a J1 phage lysate was prepared and used for infection as described previously [16], [18]. If required, the following antibiotic concentrations were used: 25 µg/ml of erythromycin for lactobacilli, 500 µg/ml of erythromycin for E. coli, 10 µg/ml of chloramphenicol for lactobacilli and E. coli, and 100 µg/ml of ampicillin for E. coli.

Plasmid construction

To construct plasmid pYCAT-asnH for complementation, asnH was amplified by PCR from ATCC 27139 genomic DNA using a primer set of HindIII–asnH (5′-CCCAAGCTTCTGGCGCAGAAACATTCTG-3′) and asnH–SalI (5′-ACGCGTCGACTCGGCTTGTGGCATCATG-3′). PCR products were digested with HindIII and SalI and subsequently ligated into the same sites of pYCAT, a derivative of the Escherichia–Lactobacillus shuttle vector pUCYIT356-1-Not2 [18] carrying the cat resistance gene from plasmid pC194 [19].

To construct plasmid expressing an AsnHWT-FLAG fusion protein, asnH was amplified from ATCC 27139 genomic DNA using a primer set of XhoI–asnH (5′-CCGCTCGAGCGGTGCGGAATCATCGCGTTTGC-3′) and XmaI–asnH (5′-CCCCCGGGGGTGCTTCAAGTTTCTCTTTAC-3′). PCR products were cloned into the XhoΙ and XmaΙ sites of pFLAG-CTC (Sigma-Aldrich Co., St. Louis, MO), generating plasmid pFLAG-AsnHWT. Plasmids expressing AsnHC2S-FLAG and AsnHD265N-FLAG were created using a QuickChange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) using a primer set of asnH_C2S-Fw (5′-CCGCTCGAGCGGTCCGGAATCATCGCGTTTGC-3′) and asnH_C2S-Rv (5′-GCAAACGCGATGATTCCGGACCGCTCGAGCGG-3′) or asnH_D265N-Fw (5′-CTTTCATCAGGGGTCAACTCCTCTTATATCACCG-3′) and asnH_D265N-Rv (5′-CGGTGATATAAGAGGAGTTGACCCCTGATGAAAG-3′). Mutations were confirmed using BigDye® Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems, Forester City, CA) by DNA sequencing on an ABI PRISM® 3130 Genetic Analyzer (Applied Biosystems).

Screening of Tn5 insertion mutants for the J1 phage-resistant phenotype

Tn5 insertion mutants were screened for their level of J1 phage resistance compared with the wild-type strain as the parental control. Mutants were inoculated into ILS broth containing J1 phage lysate at a multiplicity of infection (moi) of 10 using a 96-well plate. After incubation at 37°C for 48 h, the mutants grown in ILS broth containing J1 phage were regarded as resistant to J1 phage. To ascertain the resistance levels of the mutants to J1 phage infection, the cells of the wild-type strain and the mutants were mixed with J1 phage in ILS broth at an moi of 0.5, and the number of PFU was counted after incubation at 37°C for 24 h. Relative J1 phage sensitivity was calculated as the ratio of PFU for transposon insertion mutants to that of the wild-type strain.

Analysis of DNA sequence and identification of the transposon insertion site

Self-ligation-mediated inverse PCR was used to characterize the Tn5 insertion site, as described previously [18]. In brief, NcoI-, BanII-, or KpnI-digested chromosomal DNA from the strain carrying the Tn5 insertion was self-ligated, and inverse PCRs were performed on ligated templates using a primer set of SqFP (5′-GCCAACGACTACGCACTAGCCAAC-3′) and SqRP (5′-GAGCCAATATGCGAGAACACCCGAGAA-3′). PCR products were sequenced, and the sequences were identified using the BLAST program (http://blast.ncbi.nlm.nih.gov/BLAST.cgi; NCBI, Bethesda, MD).

Experimental infection

Animal experiments were approved by the Kitasato University Institutional Animal Care and Use Committee (Permit Number: J10-1) and were performed in accordance with the Regulations for the Care and Use of Laboratory Animals in Kitasato University and with the National Research Council Guide for the Care and Use of Laboratory Animals in Japan. Specific pathogen-free male BALB/c mice (Charles River Japan, Kanagawa, Japan) were used for the mouse infection model as described previously [16]. Briefly, the mice were injected intravenously (i.v.) with a heat-killed preparation of lactobacilli (800 µg/mouse) 6 days before Listeria infection. The L. monocytogenes strain EGD (2.0×106 CFU) was injected i.v. 6 days after lactobacilli inoculation. The number of viable Listeria in spleen homogenates 24 h after the challenge was counted; the plates containing the appropriate diluents of the homogenates were maintained at 37°C.

Cytokine detection by enzyme-linked immunosorbent assay (ELISA)

Heat-killed lactobacilli preparations (800 µg) were injected i.v. into mice. IL-12, TNF-α, and IFN-γ were measured from spleen homogenates 8 h after the challenge using OptEIA™ ELISA kits (BD Biosciences Pharmingen, San Diego, CA) as described by the manufacturer. Absorbances were measured using a model 3550 microplate reader (Bio-Rad Laboratories, Hercules, CA). Sample data were extrapolated from standard curves using Microplate Manager® 6 software (Bio-Rad Laboratories).

Expression and purification of recombinant proteins

E. coli BL21 (TaKaRa Bio, Shiga, Japan) strains containing plasmids encoding FLAG fusion proteins were grown at 37°C in LB broth overnight. The cultures were diluted 1∶100 into fresh LB broth supplemented with 0.4% (w/v) glucose and incubated at 25°C for 3 h. Isopropyl-b-d-thiogalactopyranoside was added to a final concentration of 1 mM, and the cultures were further incubated at 25°C for 5 h. To purify FLAG fusion proteins, bacteria were centrifuged at 7000×g for 10 min at 4°C and resuspended in 10 ml of CelLytic B™ reagent (Sigma-Aldrich Co.) with cOmplete, Mini protease inhibitor cocktail tablets (Roche Diagnostics Co., Basel, Switzerland). After a 15 min incubation at room temperature, samples were centrifuged at 15,000×g for 20 min at 4°C to pellet cellular debris. FLAG fusion proteins were purified using an anti-FLAG M2 affinity gel according to manufacturer's instructions (Sigma-Aldrich Co.). Protein concentrations were quantified according to the Bradford method using the protein assay dye reagent concentrate (Bio-Rad Laboratories).

Enzymatic activity of AsnH

The enzymatic activity of AsnH was measured using an Amplex® Red Glutamic Acid/Glutamate Oxidase Assay Kit (Molecular Probes, Eugene, OR) according to the methods described previously [20]. Briefly, aspartic acid or cell wall extracts of L. casei ATCC 27139, used as the substrates, were diluted with a reaction mixture containing 50 mM Tris-HCl (pH 7.5), 15 mM MgCl2, 25 mM KCl, 1 mM glutamine, 0.2 mM dithiothreitol, and 2 mM ATP. Several concentrations of glutamic acid (0–20 µM) were used as the standard. Fifty microliters of the substrate solution were added to 50 µl of the Amplex® Red reagent/horse radish peroxidase/glutamate oxidase/glutamate–pyruvate transaminase/alanine working solution. After incubation at 30°C for 30 min, luminescence was detected using a SpectraMax5 microplate reader (Molecular Devices Co., Sunnyvale, CA) with excitation at 544 nm and emission at 595 nm. Sample data were extrapolated from standard curves using Microplate Manager® 6 software (Bio-Rad Laboratories).

Gram staining and transmission electron microscopy

Gram staining of L. casei cells grown to the early stationary phase in ILS broth was performed using Fiber G (Nissui Pharmaceutical Co.), in accordance with the manufacturer's recommendations, and the cells were observed using OLYMPUS BX50 light microscope (OLYMPUS Co., Tokyo, Japan). For transmission electron microscopy (TEM) analyses, L. casei cells were fixed with 2% glutaraldehyde in 100 mM phosphate buffer (pH 7.4), postfixed in osmium tetroxide at 4°C, dehydrated, and embedded in Epon 812 resin. Ultrathin sections were analyzed using JEM-1200EX TEM (JEOL, Tokyo, Japan) at 80 kV.

Preparation of cell wall extracts

Two-hundred-milliliter cultures of L. casei grown to the early stationary phase in ILS broth were centrifuged at 8000×g at 4°C for 10 min. The cells were washed 3 times with distilled water and resuspended in 20 ml of acetone. Suspensions were centrifuged at 3000×g at 4°C for 10 min, and precipitates were washed again with acetone and suspended in 10 ml of chloroform/methanol (2∶1). Suspensions were incubated at 60°C for 30 min and centrifuged at 3000×g at 4°C for 10 min. Precipitates were resuspended in 50 mM Tris-HCl (pH 7.0) with DNaseI and RNaseA at final concentrations of 1000 U and 50 ng/µl, respectively, and incubated at 37°C for 1 h. Proteinase K was added to the lysates to a final concentration of 1 mg/ml, and suspensions were heated at 37°C for 16 h. After centrifugation at 20,000×g at 4°C for 40 min, precipitates were washed with 50 mM Tris-HCl (pH 7.0) and treated with 0.1% (w/v) sodium dodecyl sulfate in distilled water at 100°C for 10 min. Suspensions were then centrifuged at 20,000×g at 4°C for 40 min, and precipitates were washed with distilled water 6 times. Precipitates were then washed with 20% (v/v) ethanol and 5% (w/v) NaCl 3 times and again with distilled water 3 times. After centrifugation at 20,000×g at 4°C for 40 min, precipitates were lyophilized and used as cell wall extracts.

Amino acid composition of the peptidoglycans

Cell wall extracts prepared as described above were suspended in 5 ml of 10% (v/v) trichloroacetic acid and heated at 100°C for 20 min. After centrifugation at 12,000×g at 4°C for 30 min, precipitates were washed 3 times with 50 mM phosphate buffer (pH 7.2) and then with 100% (v/v) ethanol. The resultant residues were suspended with diethyl ether and centrifuged at 15,000×g at 4°C for 10 min. Precipitates were lyophilized and used as the peptidoglycan fraction. The purified peptidoglycans (1 mg) were hydrolyzed in 6 N HCl at 100°C for 16 h, and the amino acid composition was analyzed by high-performance liquid chromatography using a Waters 2695 Separations Module (Waters co., Milford, MA) composed of a C18 AccQ·Tag column, a 474 scanning fluorescence detector, and AccQ (all from Waters co.).

Sensitivity to lysozyme

To ascertain the sensitivity of L. casei strains to lysozyme, L. casei ATCC 27139 and its mutants that had been pre-incubated in ILS broth at 37°C for 48 h were inoculated at 1.0×107 CFU/ml into fresh ILS broth containing various lysozyme concentrations (0–10,000 µg/ml). Following incubation at 37°C for 48 h, the minimal inhibitory concentration of lysozyme at which L. casei strains failed to grow was regarded as its MIC.

Statistical analysis

The results of peptidoglycan thickness are presented as the means ± standard error of the mean (SEM) and the others are presented as the means ± standard deviations (SD) of triplicate experiments. Statistical analyses were performed using Student's t-test. Differences were considered significant at p<0.05.

Nucleotide sequence accession number

The sequence orthologs of the asnH gene were obtained from the DDBJ/EMBL/GenBank database. The accession numbers for the Rhodococcus erythropolis, Corynebacterium glutamicum, Mycobacterium smegmatis, and Escherichia coli sequences were AB183824, BX842579, AB183824, J05554, respectively, and GeneID of the Lactococcus lactis was 4797108. The alignment was constructed using the GENETYX program (Genetyx Co., Tokyo, Japan).

Results

Isolation of J1 phage-resistant mutants of L. casei ATCC 27139 from a random Tn5 insertion library

To identify genes involved in the augmentation of host innate immunity by L. casei, a total number of 9408 Tn5 insertion mutants from the mutant library were screened for their J1 phage sensitivity using a 96-well plate assay. Nine mutants (MT77, MT2890, MT3332, MT4156, MT5740, MT6674, MT7279, MT7398, and MT8105) displayed significantly higher resistance to J1 phage compared with the wild-type parental strain. Sensitivities to J1 phage infection of these mutants were 104-fold lower than that of the wild-type strain (Table 1). Southern hybridization analyses confirmed that all these mutants carried a single independent Tn5 transposon insertion (data not shown).

thumbnail
Download:
Table 1. Summary of relative sensitivities to J1 phage infection and predicted transposon insertion loci of J1 phage-resistant mutant.

https://doi.org/10.1371/journal.pone.0083876.t001

Inverse PCR and sequencing of the DNA regions flanking the transposon insertion sites of each J1 phage-resistant mutant indicated that asnH, dnaJ, and dnaK were disrupted by insertion of the transposon element: among the 9 Tn5 mutants, 3 mutants (MT77, MT4156, and MT8105) harbored Tn5 insertions in asnH, 5 mutants (MT2890, MT3332, MT5740, MT6674, and MT7398) carried insertions in dnaJ, and the remaining mutant (MT7279) carried a transposon insertion in dnaK.

The asnH mutant of L. casei ATCC 27139, but not the dnaJ or dnak mutants, is deficient in the immune-augmenting activity

Since previous studies have demonstrated that the heat-killed preparation of J1 phage-resistant mutants of L. casei ATCC 27139 are deficient in the immune-augmenting activity, we assessed this activity in the J1 phage-resistant Tn5 mutants obtained in this study using a mouse model of Listeria infection. Whereas mice pre-treated with L. casei dnaJ (MT3332) and dnak (MT7279) mutant strains exhibited anti-listerial activity comparable to that of the wild-type strain, the asnH mutant (MT77) showed no significant activity (Fig. 1A). The defect in anti-listerial activity in the asnH mutant resulted solely from the absence of asnH because significant protection against Listeria infection in mice could be restored to wild-type levels by introducing a plasmid harboring asnH into the mutant (Fig. 1B). As for the induction of innate cytokines such as IL-12, TNF-α, and IFN-γ in the host, the asnH mutant did not induce significant levels of cytokines, and complementation of the asnH mutant with a plasmid expressing intact AsnH restored the cytokine production comparable to that of the wild-type strain (Fig. 2).

thumbnail
Download:
Figure 1. Anti-listerial activity of J1 phage-resistant Tn5 insertion mutants of L. casei.

Heat-killed preparations of L. casei ATCC 27139 or isogenic Tn5 insertion mutants (800 µg) were injected i.v. into BALB/c mice 6 days before an i.v. challenge with L. monocytogenes (2.0×106 CFU/mouse). Six mice per group were dissected 24 h after the challenge, and viable Listeria were detected in spleens. Columns: white, saline; black, L. casei wild-type; slashed, L. casei J1 phage-resistant mutant; gray, L. casei asnH mutant complemented with the cloned asnH. Results are depicted as the means ± standard deviations (SD). Statistical significance was calculated using the Student's t-test. Significant differences indicated between the control and treated groups. ***, p<0.001.

https://doi.org/10.1371/journal.pone.0083876.g001

thumbnail
Download:
Figure 2. Induction of cytokine in spleen after L. casei administration.

Heat-killed preparations of L. casei ATCC 27139 or isogenic Tn5 insertion mutants (800 µg) were injected i.v. into BALB/c mice. Six mice per group were sacrificed 8 h after injection, and IL-12 (A), TNF-α (B), and IFN-γ (C) proteins were measured from spleen homogenates by ELISA. Columns: white, saline; black, L. casei wild-type; slashed, L. casei J1 phage-resistant mutant; gray, L. casei asnH mutant complemented with the cloned asnH. Results are depicted as the means ± standard deviations (SD). Statistical significance was calculated using the Student's t-test. Significant differences indicated between the control and treated groups. ***, p<0.001.

https://doi.org/10.1371/journal.pone.0083876.g002

AsnH is an asparagine synthetase with glutamine amidotransferase activity

asnH (1,878 bp) of L. casei ATCC 27139 encodes a 625-amino acid product with a predicted molecular mass of 73 kDa. A homology search determined that the asnH product has significant homology to the LtsA/AsnB glutamine amidotransferase family of proteins that have been identified in various Gram-positive and Gram-negative bacteria. The glutamine amidotransferase family includes proteins composed of an N-terminal glutaminase domain and a C-terminal synthetase domain with conserved amino acid motifs [20], [21]. In AsnH of L. casei ATCC 27139, amino acid residues Cys-2, Arg-48, Asn-73, Glu-75, and Asp-97, which are essential for glutaminase activity of the N-terminal domain, and amino acid residues Ser-261, Asp-265, Ser-266, Gly-355, Asp-359, Lys-525, and Lys-545, which are required for catalytic activity of the C-terminal domain, are invariant (Fig. 3A) [20], [22]–[24].

thumbnail
Download:
Figure 3. Schematic diagram of L. casei AsnH and glutaminase activity of AsnH proteins.

(A) Protein sequence alignment was performed using the GENETYX program. Solid boxes indicate highly conserved regions. Regions containing residues important for enzymatic activities are shown in detail (identical residues are indicated by boldface type). The first methionine was consistently included in the numbering and was designated Met-1. Asterisks indicate mutated residues in this study that were critical to glutaminase or synthetase activities. (B) Recombinant AsnHWT, mutant AsnHC2S, and mutant AsnHD265N (0.1 µg) were examined using the glutaminase activity test. Five microliters of a reaction mixture (initial volume, 50 µl) were quenched at 30 min to estimate glutamic acid concentration. Glutaminase activity was monitored in the presence of aspartic acid or cell wall extracts of ATCC 27139, ATP or AMP–PNP plus cell wall extracts. Results are depicted as the means ± standard deviations (SD). Statistical significance was calculated using the Student's t-test. Significant differences indicated between the control and treated groups. ***, p<0.001.

https://doi.org/10.1371/journal.pone.0083876.g003

To determine whether AsnH possess glutamine amidotransferase activity, we conducted an in vitro glutamic acid production assay. Glutaminase activity can be enhanced by the addition of an amide acceptor such as aspartic acid for E. coli AsnB or lysozyme-treated cell wall extracts for Rhodococcus erythropolis LtsA [20]. Incubation of the purified AsnHWT-FLAG fusion proteins with glutamine resulted in glutamic acid production at a rate of 6.6 µM/h when lysozyme-treated cell wall extracts of L. casei ATCC 27139, but not aspartic acid, was added in the reaction mixture (Fig. 3B). To further characterize the AsnH as a glutamine amidotransferase, we used site-directed mutagenesis to replace the conserved N-terminal Cys-2 with Ser-2 and the conserved C-terminal Asp-265, which is located in the putative ATP-binding pocket of the synthetase domain, with Asn-265. The AsnHC2S-FLAG and AsnHD265N-FLAG mutant proteins failed to produce glutamic acid (Fig. 3B). In AsnB of E. coli, ATP and aspartic acid form a catalytic intermediate and NH3 is transferred to the amide acceptor [21]. To test whether the enzymatic activity of AsnH of L. casei is enhanced by ATP hydrolysis, a non-hydrolyzable ATP analog, AMP–PNP [adenosine 5′-(βγ-imido) triphosphate], was used instead of ATP in the reaction. No glutamic acid production was detected in the AMP–PNP reaction mixture (Fig. 3B).

Structural analysis of the asnH mutant cell wall

AsnH of Lactococcus lactis and LtsA of R. erythropolis are involved in cell wall biosynthesis, and the mutations in asnH or ltsA confer increased bacterial sensitivity to lysozyme [20], [25]. L. casei wild-type and asnH-complemented mutant strains were stained Gram positive, while the asnH mutant (MT77) was stained Gram negative (Fig. 4A). TEM observations of L. casei cells showed that the peptidoglycan layers of the mutant cells were significantly thinner (Fig. 4BC) and the cell size appeared to be larger when compared with those of the wild-type and the complemented cells (Fig. 4B).

thumbnail
Download:
Figure 4. Micrographs of L. casei cells.

(A) Gram staining was performed using Fiber G. The cells were observed under a light microscope (×1000). (B) Representative micrographs indicating cell morphologies in several different fields. Digitally magnified (×3) views of typical cell surfaces are shown in the insets. Scale bars = 100 nm. PS, polysaccharide; PG, peptidoglycan; CP, cytoplasm. (C) Peptidoglycan thickness of L. casei cells are presented as the means ± standard error of the mean (SEM) (n = 5). Statistical significance was calculated using the Student's t-test. *, p<0.05; **, p<0.01; ***, p<0.001.

https://doi.org/10.1371/journal.pone.0083876.g004

In L. casei, the peptidoglycan stem peptide is composed of the tetrapeptide chain containing l-Ala-d-Glu-d-Lys-d-Ala, which is cross-linked with a d-Asp residue (Fig. 5) [26]. To evaluate the effect of asnH mutation on the cell wall structure, we analyzed the amino acid composition of the peptidoglycan layers of the L. casei cells. The molar ratio of Asp in the peptidoglycans extracted from the asnH mutant strain was lower than that of extracts from the wild-type and the complemented strains (Table 2).

thumbnail
Download:
Figure 5. Schematic representation of disaccharide tetrapeptide with crossbridge in peptidoglycan of L. casei.

GluNAc: N-acetyl glucosamine, MurNAc: N-acetyl muramic acid, L-Ala: L-alanine, D-Glu: D-glutamic acid, L-Lys: L-lysine, D-Ala: D-alanine, D-Asp: D-aspartic acid, D-Asn: D-asparagine.

https://doi.org/10.1371/journal.pone.0083876.g005

thumbnail
Download:
Table 2. Amino acid compositions in peptidoglycans and lysozyme MICs of J1 phage-resistant mutants.

https://doi.org/10.1371/journal.pone.0083876.t002

The lysozyme MIC of the asnH mutant (MT77) was 80 µg/ml, which is far lower than that of the wild-type strain as: >10,000 µg/ml (Table 2). The asnH-complemented strain displayed a lysozyme resistance comparable to the wild-type strain (Table 2). The vancomycin MIC of the asnH mutant was 8-fold lower than that of the wild-type and the complemented strains (data not shown).

Identification of the mutated region of MNNG-induced J1 phage-resistant mutants

We previously demonstrated that J1 phage-resistant mutants, which were obtained by chemical mutagenization of L. casei ATCC 27139 with N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), exhibited the lower immune-augmenting activity [27]. To further clarify that AsnH is implicated in the activity, we cloned asnH from the MNNG-induced J1 phage-resistant mutants (strains 27139-J1R1, 27139-J1R2, 27139-J1R3, and 27139-J1R4). The mutation sites in the genes were found to be either a deletion (C-1207 deletion in 27139-J1R1) or displacement (G-788 to A-788 in J1R2, G-1486 to A-1486 in J1R3, and G-88 to A-88 in J1R4) of a base in asnH, resulting in frameshift (J1R1) or missense mutations (Gly-263 to Glu-263 in J1R2, Glu-496 to Lys-496 in J1R3, and Gly-30 to Ser-30 in J1R4) of AsnH (Fig. 6). These mutated residues are among the evolutionarily conserved amino acids essential for enzymatic activity of members of the LtsA/AsnB glutamine amidotransferase family (Fig. 6). Introducing a plasmid harboring asnH into the MNNG-induced J1 phage-resistant mutant strains recovered the J1 phage-sensitive phenotype (Table 3) and restored the immunoprotective effects associated with Listeria infection in mice (data not shown).

thumbnail
Download:
Figure 6. Partial sequence alignment of L. casei AsnH and orthologs.

Partial sequences were selected from highly conserved regions of the following L. casei AsnH orthologs: L. lactis, R. erythropolis, M. smegmatis, and E. coli. A black background indicates identical residues in all bacteria.

https://doi.org/10.1371/journal.pone.0083876.g006

thumbnail
Download:
Table 3. Relative sensitivities to J1 phage infection among MNNG-induced J1 phage-resistant mutants.

https://doi.org/10.1371/journal.pone.0083876.t003

Discussion

Heat-killed L. casei ATCC 27139 significantly augments innate immunity in mice [16], [27]. This immunoprotective effect is lost in J1 phage-resistant mutants [16], [27], suggesting that certain cell wall components associated with J1 phage sensitivity are involved in the activation of host innate immunity. In this study, we used a Tn5 insertion library to demonstrate that asnH, dnaJ, and dnaK are coordinated with J1 phage sensitivity, and only asnH mutants lost the ability to enhance host innate immunity. Complementation of the asnH mutant strains with the cloned asnH recovered the activity. MNNG-induced J1 phage-resistant mutants lacking the capacity to augment innate immunity all had mutated asnH, reinforcing the idea that asnH is essential for the activity of L. casei ATCC 27139 to boost host innate immunity.

DnaJ and DnaK proteins are molecular chaperones that regulate protein folding and function as heat shock proteins [28]. Because the dnaJ and dnaK mutants of L. casei ATCC 27139 displayed anti-listerial activity equivalent to the wild-type strain, it is unlikely that the dnaJ or dnaK gene contributes to the immune-augmenting activity. Loss of innate immunity-augmenting activity in J1 phage-resistant mutants does not result simply from the phage resistance but from a specific phenomenon related to the loss of AsnH activity.

Asparagine synthetase, which consists of glutaminase activity and synthetase activity, catalyzes asparagine and glutamic acid biosynthesis from aspartic acid and glutamine, respectively [29], [30]. The synthetase activity of the C-terminal domain recognizes an amide donor and forms an intermediate before the glutaminase activity of the N-terminal domain hydrolyzes an amide donor, and this involves an ATP-dependent transfer of ammonia to aspartic acid yielding asparagine in the presence of magnesium ion [31]. Although glutamine-hydrolyzing AsnB of several bacteria utilizes glutamine as an amide donor [32], [33] and glutaminase activity is markedly enhanced when the amide acceptor aspartic acid is added in the reaction mixture [24], glutaminase activity of R. erythropolis LtsA is enhanced significantly when lysozyme-treated cell wall extracts are added instead of aspartic acid in the reaction mixture [20]. In the present study, L. casei ATCC 27139 AsnH displayed marked glutaminase activity when the lysozyme-treated cell wall extracts of ATCC 27139 were added instead of aspartic acid, strongly suggesting that components of the lysozyme-treated cell wall extracts serve as amide acceptors. L. lactis AsnH, which exhibits 59% amino acid sequence identity with the L. casei AsnH, is involved in amidation of d-Asp present in the interpeptide cross-bridge of peptidoglycan (Fig. 5) [25]. In the maturation of L. lactis peptidoglycan, approximately 75% of the side chain and cross-bridge residues are amidated, indicating that d-Asp is converted to d-Asn [34]. Homologous genes have been identified in other Gram-positive bacterial species that possess d-Asn in their cross-bridges, and L. casei peptidoglycan also possesses d-Asn in its cross-bridges [35]. In this study, the assays of the asnH-mutant cells about lysozyme sensitivity, Gram staining, and TEM observations showed the lack of the thick and rigid peptidoglycan features that are characteristic to the wild-type cells, indicating that AsnH is required for the synthesis of intact peptidoglycans. Sequence analysis by SignalP [36] indicates that AsnH contains neither a putative signal peptide nor a transmembrane segment, suggesting that AsnH is localized inside the bacterial cytoplasm and that this protein most probably acts on peptidoglycan precursors. Although the analysis of amino acid compositions in peptidoglycan of the asnH mutant cells showed a decrease in aspartic acid content, further experiments would be needed to elucidate where AsnH protein acts on the peptidoglycan. Peptidoglycan and derived muropeptides in L. salivarius showed protective effect in murine colitis mice model through induction of pathogen-associated molecular pattern receptors such as Nod2 [37], which recognizes intracellular muramyl dipeptide of a peptidoglycan constituent [38], suggesting the relevance of peptidoglycan structure to the immune-augmenting activity of L. casei ATCC 27139.

On the other hand, the changed amino acid compositions in peptidoglycan may affect the immune signaling by non-peptidoglycan molecules. Cell surface polysaccharide components, d-galactosamine and l-rhamnose, in L. casei ATCC 27139/S-1 comprise a phage receptor for J1 phage, and J1 phage-resistant mutant lacked d-galactosamine in its surface components [39]. In this study, although no significant difference in the polysaccharide thickness between the wild-type and the asnH mutant cells has been identified (data not shown), the amount of polysaccharide in the asnH mutant cells appeared to be less organized. In L. casei strain Shirota, polysaccharide-peptidoglycan complexes play important roles in augmenting host innate immunity [7], [40], which, taken together, suggests the relevance of cell surface polysaccharide components to the immune-activating capacity of L. casei ATCC 27139. Teichoic acids in L. plantarum has been shown to modulate intestinal and systemic immune responses in a TLR2-dependent manner [41]. TLR2 recognizes bacterial components such as lipoteichoic acid, lipoprotein [42], [43], LPS [44], [45], the mycobacterial lipoarabinomannan [46], and heat-killed Gram-positive bacteria [47]. L. casei ATCC 27139-J1R1, asnH mutant, lost the capacity to induce TLR2 and Nod2 [16]. Demonstration of the differences in the amount of cell wall components between the wild-type and the asnH mutant cells might lead to further elucidation of the components and structures that enhance host innate immunity.

In conclusion, asnH of the probiotic L. casei ATCC 27139 is suggested to be involved in the immune-activating capacity of this strain. asnH contributes to peptide synthesis in the peptidoglycan layer, indicating that certain cell wall structures of L. casei are important in the enhancement of host innate immunity. These findings should facilitate the characterization of active components and structures in probiotic lactobacilli to augment host innate immunity.

Acknowledgments

We are grateful to Katsuhisa Harada, Hiroshi Sakon, Ayane Shimazaki, Tomoya Okada, and Ruui Tsubota for their technical work. We thank Takeshi Haneda and Tsuyoshi Miki for their helpful assistance.

Author Contributions

Conceived and designed the experiments: MI YGK HT KN HD NO. Performed the experiments: MI YGK TT. Analyzed the data: MI. Contributed reagents/materials/analysis tools: MI YGK TT MK. Wrote the paper: MI HT KN NO.

References

  1. 1. Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16: 658–672.
  2. 2. Shida K, Nanno M (2008) Probiotics and immunology: separating the wheat from the chaff. Trends Immunol 29: 565–573.
  3. 3. Takeda K, Okumura K (2007) Effects of a Fermented Milk Drink Containing Lactobacillus casei Strain Shirota on the Human NK-Cell Activity. J Nutr 137: 791S–793S.
  4. 4. Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, et al. (2006) Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146: 109–115.
  5. 5. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, et al. (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27: 104–109.
  6. 6. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, et al. (2002) Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68: 273–280.
  7. 7. Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, et al. (1985) Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. J Clin Lab Immunol 17: 91–97.
  8. 8. Yokokura T, Nomoto K, Shimizu T, Nomoto K (1986) Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect Immun 52: 156–160.
  9. 9. Miake S, Nomoto K, Yokokura T, Yoshikai Y, Mutai M (1985) Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice. Infect Immun 48: 480–485.
  10. 10. Matsuzaki T, Hashimoto S, Yokokura T (1996) Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice. Med Microbiol Immunol (Berl) 185: 157–161.
  11. 11. Kato I, Kobayashi S, Yokokura T, Mutai M (1981) Antitumor activity of Lactobacillus casei in mice. Gann 72: 517–523.
  12. 12. Matsuzaki T, Yokokura T (1987) Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei. Cancer Immunol Immunother 25: 100–104.
  13. 13. Matsuzaki T, Yokokura T, Azuma I (1987) Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer Immunol Immunother 24: 99–105.
  14. 14. Matsuzaki T, Yokokura T, Azuma I (1985) Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol Immunother 20: 18–22.
  15. 15. Shimizu-Kadota M, Kiwaki M, Sawaki S, Shirasawa Y, Shibahara-Sone H, et al. (2000) Insertion of bacteriophage phiFSW into the chromosome of Lactobacillus casei strain Shirota (S-1): characterization of the attachment sites and the integrase gene. Gene 249: 127–134.
  16. 16. Kim YG, Ohta T, Takahashi T, Kushiro A, Nomoto K, et al. (2006) Probiotic Lactobacillus casei activates innate immunity via NF-κB and p38 MAP kinase signaling pathways. Microbes Infect 8: 994–1005.
  17. 17. Capra ML, Quiberoni A, Reinheimer J (2006) Phages of Lactobacillus casei/paracasei: response to environmental factors and interaction with collection and commercial strains. J Appl Microbiol 100: 334–342.
  18. 18. Ito M, Kim YG, Tsuji H, Kiwaki M, Nomoto K, et al. (2010) A practical random mutagenesis system for probiotic Lactobacillus casei using Tn5 transposition complexes. J Appl Microbiol 109: 657–666.
  19. 19. Byeon WH, Weisblum B (1984) Post-transcriptional regulation of chloramphenicol acetyl transferase. J Bacteriol 158: 543–550.
  20. 20. Mitani Y, Meng X, Kamagata Y, Tamura T (2005) Characterization of LtsA from Rhodococcus erythropolis, an enzyme with glutamine amidotransferase activity. J Bacteriol 187: 2582–2591.
  21. 21. Larsen TM, Boehlein SK, Schuster SM, Richards NG, Thoden JB, et al. (1999) Three-dimensional structure of Escherichia coli asparagine synthetase B: a short journey from substrate to product. Biochemistry 38: 16146–16157.
  22. 22. Mei B, Zalkin H (1989) A cysteine-histidine-aspartate catalytic triad is involved in glutamine amide transfer function in purF-type glutamine amidotransferases. J Biol Chem 264: 16613–16619.
  23. 23. Miller MT, Bachmann BO, Townsend CA, Rosenzweig AC (2001) Structure of β-lactam synthetase reveals how to synthesize antibiotics instead of asparagine. Nat Struct Biol 8: 684–689.
  24. 24. Boehlein SK, Richards NG, Walworth ES, Schuster SM (1994) Arginine 30 and asparagine 74 have functional roles in the glutamine dependent activities of Escherichia coli asparagine synthetase B. J Biol Chem 269: 26789–26795.
  25. 25. Veiga P, Erkelenz M, Bernard E, Courtin P, Kulakauskas S, et al. (2009) Identification of the asparagine synthase responsible for d-Asp amidation in the Lactococcus lactis peptidoglycan interpeptide crossbridge. J Bacteriol 191: 3752–3757.
  26. 26. Billot-Klein D, Legrand R, Schoot B, van Heijenoort J, Gutmann L (1997) Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics. J Bacteriol 179: 6208–6212.
  27. 27. Ohashi T, Minamishima Y, Yokokura T, Mutai M (1989) Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei. Biotherapy 1: 89–95.
  28. 28. Ang D, Liberek K, Skowyra D, Zylicz M, Georgopoulos C (1991) Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266: 24233–24236.
  29. 29. Hughes CA, Beard HS, Matthews BF (1997) Molecular cloning and expression of two cDNAs encoding asparagine synthetase in soybean. Plant Mol Biol 33: 301–311.
  30. 30. Humbert R, Simoni RD (1980) Genetic and biomedical studies demonstrating a second gene coding for asparagine synthetase in Escherichia coli. J Bacteriol 142: 212–220.
  31. 31. Zalkin H (1993) The amidotransferases. Adv Enzymol Relat Areas Mol Biol 66: 203–309.
  32. 32. Ren H, Liu J (2006) AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs. Antimicrob Agents Chemother 50: 250–255.
  33. 33. Hirasawa T, Wachi M, Nagai K (2000) A mutation in the Corynebacterium glutamicum ltsA gene causes susceptibility to lysozyme, temperature-sensitive growth, and l-glutamate production. J Bacteriol 182: 2696–2701.
  34. 34. Courtin P, Miranda G, Guillot A, Wessner F, Mezange C, et al. (2006) Peptidoglycan structure analysis of Lactococcus lactis reveals the presence of an l,d-carboxypeptidase involved in peptidoglycan maturation. J Bacteriol 188: 5293–5298.
  35. 35. Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407–477.
  36. 36. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783–795.
  37. 37. Fernandez EM, Valenti V, Rockel C, Hermann C, Pot B, et al. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1050–1059.
  38. 38. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509–5512.
  39. 39. Yokokura T (1977) Phage receptor material in Lactobacillus casei. J Gen Microbiol 100: 139–145.
  40. 40. Hashimoto S, Nomoto K, Nagaoka M, Yokokura T (1987) In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants. Cancer Immunol Immunother 24: 1–7.
  41. 41. Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, et al. (2013) The impact of Lactobacillus plantarum WCFS1 teichoic acid d-alanylation on the generation of effector and regulatory T-cells in healthy mice. PLoS One 8: e63099.
  42. 42. Liu Y, Wang Y, Yamakuchi M, Isowaki S, Nagata E, et al. (2001) Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-κB activation. Infect Immun 69: 2788–2796.
  43. 43. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406–17409.
  44. 44. Faure E, Thomas L, Xu H, Medvedev A, Equils O, et al. (2001) Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J Immunol 166: 2018–2024.
  45. 45. Matsuguchi T, Takagi K, Musikacharoen T, Yoshikai Y (2000) Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 95: 1378–1385.
  46. 46. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, et al. (2002) Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100: 1860–1868.
  47. 47. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, et al. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1–5.